Omeros Corp. (OMER)
10.59
-0.65
(-5.78%)
USD |
NASDAQ |
Dec 11, 16:00
10.62
+0.03
(+0.28%)
After-Hours: 20:00
Omeros Cash from Investing (Quarterly): -6.861M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Abbott Laboratories | -457.00M |
| Johnson & Johnson | -542.00M |
| Eli Lilly & Co. | -2.983B |
| GeoVax Labs, Inc. | 0.00 |
| Vistagen Therapeutics, Inc. | -0.094M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -18.47M |
| Cash from Financing (Quarterly) | 25.82M |
| Free Cash Flow | -105.32M |
| Free Cash Flow Per Share (Quarterly) | -0.2789 |
| Free Cash Flow to Equity (Quarterly) | 0.088M |
| Free Cash Flow to Firm (Quarterly) | -18.48M |
| Free Cash Flow Yield | -16.51% |